Psychiatry & Neurology Doctors in Long Island City, NY Accepting Medicare

16 Psychiatry & Neurology doctors found. Showing 1 - 16

Ashley Roque, MD Psychiatry & Neurology - Hospice and Palliative Medicine Medicare: Medicare Enrolled Practice Location: 3030 Northern Blvd, Long Island City, NY 11101 Phone: 212-609-1920

Dr. Tiffany A. Cummins, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 2976 Northern Blvd, Long Island City, NY 11101 Phone: 212-691-7554

Dr. Celena Dancourt, M.D Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 4136 27th St, Long Island City, NY 11101 Phone: 718-389-5100

Dr. Michael Chang, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 4140 27th St, Long Island City, NY 11101 Phone: 718-784-2240    Fax: 347-579-0518

Wlodek Skranovski, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 27-19 33 Street, Bridge Plaza/arbor We Care, Long Island City, NY 11101 Phone: 718-786-3921    Fax: 718-206-0051

Ardyce Holmen, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 4209 28th St, Long Island City, NY 11101 Phone: 347-396-6922

Dr. Sham S Mendiratta, M.D. Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 2747 Crescent St, 203, Long Island City, NY 11102 Phone: 718-721-1800    Fax: 718-721-3004

Dr. Adefolake Oshodi, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 531 50th Ave, Ground Floor, Long Island City, NY 11101 Phone: 646-308-1588

Dr. Navjot Kaur Brainch, M.B.B.S. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 3100 47th Ave Ste 3100, Long Island City, NY 11101 Phone: 888-684-2779

Le-ben Wan, MD Psychiatry & Neurology - Psychiatry Medicare: May Accept Medicare Assignments Practice Location: 4402 23rd St Ste 504, Long Island City, NY 11101 Phone: 929-322-4236

Dr. Jonathan Derk Zimmerman, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 2101 41st Ave, Long Island City, NY 11101 Phone: 718-784-2240    Fax: 833-638-0408

Dr. Melanie Israelovitch, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 41-40 27th Street, The Floating Hospital At Long Island City, Long Island City, NY 11101 Phone: 718-784-0240

Jose Vito, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Medicare Enrolled Practice Location: 4136 27th St, Long Island City, NY 11101 Phone: 718-389-5100    Fax: 718-391-9633

Dr. Gabriella Inczedy Farkas, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 3245 Hunters Point Ave, Long Island City, NY 11101 Phone: 845-279-5908    Fax: 845-622-5055

Richard Ronner, NP Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 4415 34th Ave Apt 3d, Long Island City, NY 11101 Phone: 917-929-8430

Marcel Green, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 4325 Hunter St Apt 3113w, Long Island City, NY 11101 Phone: 347-426-7005

News Archive

Parasites in patients who relapse after leishmaniasis treatment may have greater infectivity

Relapses after treatment for Leishmania infection may be due to a greater infectivity of the parasite rather than drug resistance, as has been previously thought, according to a study published in mBio-, the online open-access journal of the American Society for Microbiology.

AFFiRiS announces preclinical results of monoclonal antibody mAB C6-17 in Huntington's

AFFiRiS, a clinical-stage biotechnology company developing novel disease-modifying specific active immunotherapies, today announced that detailed preclinical results with its monoclonal antibody mAB C6-17 to treat Huntington's Disease were published in the peer-reviewed journal Neurobiology of Disease.

Spherix effects 1-for-10 reverse stock split

Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it has filed a Certificate of Amendment to its Certificate of Incorporation, as amended, to effect a 1-for-10 reverse stock split of its common stock that will become effective at end of business today.

Neurologix reports lower net loss of $3.5M for first-quarter 2010

Neurologix, Inc., a biotechnology company developing innovative gene therapies for the brain and central nervous system, today announced its financial results for the quarter ended March 31, 2010.

David Cameron obesity benefit proposals "ethically and financially questionable"

The UK Prime Minister's recent proposal to cut sickness benefit for people who are obese and refuse treatment is ethically and financially flawed, according to an Editorial in The Lancet Diabetes & Endocrinology journal.

Read more Medical News

› Verified 3 days ago